Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heng

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Current Drug Targets|September 16, 2010
Genetic and epigenetic heterogeneity in cancer: the ultimate challenge for drug therapyH H Heng, G Liu, J B Stevens, et al.
Journal of Diabetes|October 15, 2017
Re-examining the sensitivity of HbA1c to screen for diabetes mellitusChun W Yap, Yee G Ang, Timothy P L Quek, et al.
Genomics|November 5, 1997
PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7L R Osborne, J A Herbrick, T Greavette, et al.
Emerging Infectious Diseases|July 19, 2005
Asymptomatic SARS coronavirus infection among healthcare workers, SingaporeAnnelies Wilder-Smith, Monica D Teleman, Bee H Heng, et al.
Cancer Letters|February 28, 2026
Therapy-induced rapid drug resistance driven by genome chaos and polyploid giant cancer cellsSteven D Horne, Jing Christine Ye, Guo Liu, et al.
Chromosoma|August 20, 1997
Rad51 immunocytology in rat and mouse spermatocytes and oocytesP B Moens, D J Chen, Z Shen, et al.
Placenta|March 30, 2010
Nuclear matrix association: switching to the invasive cytotrophoblastK J Drennan, A K Linnemann, A E Platts, et al.
International Journal of Surgical Pathology|August 9, 2001
Pleomorphic Angiomyolipoma of Digestive Tract: A Heretofore Unrecognized EntityManju L. Prasad, John P. Keating, H. Heng Teoh, et al.
Human Gene Therapy|March 27, 1999
Nontargeted stable integration of recombinant adeno-associated virus into human leukemia and lymphoma cell lines as evaluated by fluorescence in situ hybridizationF Omori, H A Messner, C Ye, et al.
Medical Oncology (Northwood, London, England)|July 5, 2022
Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomesJason A Somarelli, James DeGregori, Marco Gerlinger, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Current Drug Targets|September 16, 2010
Genetic and epigenetic heterogeneity in cancer: the ultimate challenge for drug therapyH H Heng, G Liu, J B Stevens, et al.
Journal of Diabetes|October 15, 2017
Re-examining the sensitivity of HbA1c to screen for diabetes mellitusChun W Yap, Yee G Ang, Timothy P L Quek, et al.
Genomics|November 5, 1997
PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7L R Osborne, J A Herbrick, T Greavette, et al.
Emerging Infectious Diseases|July 19, 2005
Asymptomatic SARS coronavirus infection among healthcare workers, SingaporeAnnelies Wilder-Smith, Monica D Teleman, Bee H Heng, et al.
Cancer Letters|February 28, 2026
Therapy-induced rapid drug resistance driven by genome chaos and polyploid giant cancer cellsSteven D Horne, Jing Christine Ye, Guo Liu, et al.
Chromosoma|August 20, 1997
Rad51 immunocytology in rat and mouse spermatocytes and oocytesP B Moens, D J Chen, Z Shen, et al.
Placenta|March 30, 2010
Nuclear matrix association: switching to the invasive cytotrophoblastK J Drennan, A K Linnemann, A E Platts, et al.
International Journal of Surgical Pathology|August 9, 2001
Pleomorphic Angiomyolipoma of Digestive Tract: A Heretofore Unrecognized EntityManju L. Prasad, John P. Keating, H. Heng Teoh, et al.
Human Gene Therapy|March 27, 1999
Nontargeted stable integration of recombinant adeno-associated virus into human leukemia and lymphoma cell lines as evaluated by fluorescence in situ hybridizationF Omori, H A Messner, C Ye, et al.
Medical Oncology (Northwood, London, England)|July 5, 2022
Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomesJason A Somarelli, James DeGregori, Marco Gerlinger, et al.
Pageof 18